KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 98 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $403,439 | +7.4% | 41,895 | +0.4% | 0.00% | – |
Q2 2023 | $375,579 | +123040.7% | 41,731 | +7.5% | 0.00% | – |
Q1 2023 | $305 | +20.1% | 38,822 | +3.3% | 0.00% | – |
Q4 2022 | $254 | -100.0% | 37,585 | +0.2% | 0.00% | -100.0% |
Q3 2022 | $544,000 | +59.5% | 37,513 | +8.2% | 0.00% | – |
Q2 2022 | $341,000 | +4.6% | 34,669 | +56.5% | 0.00% | – |
Q1 2022 | $326,000 | +29.4% | 22,150 | +16.3% | 0.00% | – |
Q4 2021 | $252,000 | -24.3% | 19,050 | -0.1% | 0.00% | – |
Q3 2021 | $333,000 | -23.4% | 19,061 | +4.9% | 0.00% | -100.0% |
Q2 2021 | $435,000 | -26.9% | 18,164 | -21.6% | 0.00% | 0.0% |
Q1 2021 | $595,000 | +64.8% | 23,177 | +22.1% | 0.00% | – |
Q4 2020 | $361,000 | +82.3% | 18,989 | +20.5% | 0.00% | – |
Q3 2020 | $198,000 | -7.5% | 15,753 | -10.7% | 0.00% | – |
Q2 2020 | $214,000 | +161.0% | 17,650 | +64.5% | 0.00% | – |
Q1 2020 | $82,000 | -57.7% | 10,727 | -1.4% | 0.00% | – |
Q4 2019 | $194,000 | +57.7% | 10,877 | +2.2% | 0.00% | – |
Q3 2019 | $123,000 | -48.1% | 10,639 | -0.7% | 0.00% | – |
Q2 2019 | $237,000 | – | 10,719 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 422,310 | $10,849,000 | 5.86% |
COMMODORE CAPITAL LP | 214,467 | $5,510,000 | 2.20% |
Vivo Capital, LLC | 1,863,296 | $47,868,000 | 1.68% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 214,533 | $5,486,000 | 1.45% |
Nicholas Investment Partners, LP | 594,130 | $15,263,000 | 1.06% |
Altium Capital Management LP | 128,130 | $3,292,000 | 0.91% |
Affinity Asset Advisors, LLC | 100,000 | $2,569,000 | 0.87% |
SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $1,285,000 | 0.70% |
APIS CAPITAL ADVISORS, LLC | 30,000 | $771,000 | 0.70% |
Birchview Capital, LP | 40,000 | $1,028,000 | 0.61% |